Skip to content

Clinical trials

Myeloproliferative Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: France Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20053
20071
20081
20101
20111
20121
20134
20147
20153
20163
20172
20182
20199
20206
20217
20225
20238
20247
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting16
Active, not recruiting10
Terminated9
Unknown status7
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation8
University Hospital, Brest8
Novartis Pharmaceuticals6
University Hospital, Bordeaux6
Assistance Publique - Hôpitaux de Paris4
University Hospital, Angers4
Celgene3
European Organisation for Research and Treatment of Cancer - EORTC3
AOP Orphan Pharmaceuticals AG2
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders78
Primary Myelofibrosis27
Polycythemia Vera20
Thrombocythemia, Essential18
Hematologic Diseases15
Leukemia14
Bone Marrow Diseases13
Leukemia, Myeloid, Acute10
Myelodysplastic Syndromes10
Leukemia, Myelomonocytic, Chronic9

Trials

Showing 51 to 75 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.